Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

2.260 +0.010 (+0.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,187,255
Open 2.250
Bid (Size) 2.250 (3)
Ask (Size) 2.270 (5)
Prev. Close 2.250
Today's Range 2.200 - 2.320
52wk Range 1.670 - 17.65
Shares Outstanding 198,755,831
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ocugen's Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years
 
Via Benzinga
7 Stocks to Short Before July 2022
There are many highly overvalued publicly traded companies that will have trouble staying afloat, giving investors many stocks to short. 
Via InvestorPlace

Performance

YTD
-52.12%
-52.12%
1 Month
-4.64%
-4.64%
3 Month
-36.87%
-36.87%
6 Month
-52.12%
-52.12%
1 Year
-73.81%
-73.81%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022
Via Benzinga
Ocugen Diversifies Its Pipeline With New Cell Therapy Platform
Via Benzinga
OCGN Stock Falls Despite Positive FDA Update
Via InvestorPlace
FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial
Via Benzinga
The Top Reasons to Avoid the Ocugen Stock
Via InvestorPlace
Earnings Scheduled For May 6, 2022
Via Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
Via Benzinga
Why Ocugen Shares Are Trading Higher Today
Via Benzinga
Why Is Ocugen (OCGN) Stock Down Today?
Via InvestorPlace
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
Via InvestorPlace
State Street Just Bought Ocugen (OCGN) Stock. Here’s Why.
Via InvestorPlace
Why Is Lixte Biotechnology (LIXT) Stock Up Today?
Via InvestorPlace
FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial
Via Benzinga
Here's Why Ocugen Shares Are Falling
Via Benzinga
What the WHO Snub Means For Ocugen Stock Investors?
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Up 10% Today?
Via InvestorPlace
Read Why Did WHO Suspend UN Supply of Bharat Biotech's Covaxin COVID-19 Vaccine
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
These Were The 20 Most Searched Tickers On Benzinga In The First Quarter: Did Your Favorite Stock Make The List?
Via Benzinga
It’s Time to Get Clinical, Not Cynical, With Ocugen Stock
Via InvestorPlace
The Biggest Reasons to Avoid Ocugen for Now
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.